Search research articles
Contact Us
Filters
Showing results (951-960 of 1,520) with videos related to
Page
of 152
Sort By:
Biochemical and Biophysical Research Communications
|
October 12, 2000
Influence of oligomer chain length on the antioxidant activity of procyanidins
S B Lotito, L Actis-Goretta, M L Renart, et al.
Lancet (London, England)
|
July 1, 1995
Treatment of HIV-associated Kaposi's sarcoma with paclitaxel
M W Saville, J Lietzau, J M Pluda, et al.
Blood
|
January 1, 1995
Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies
J Whang-Peng, T Knutsen, E S Jaffe, et al.
Thrombosis Research
|
December 15, 2015
Head trauma is the major risk factor for cerebral sinus-vein thrombosis
Ornit Giladi, David M Steinberg, Kobi Peleg, et al.
Annals of Internal Medicine
|
August 15, 1990
Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy
J M Pluda, R Yarchoan, E S Jaffe, et al.
Journal of Clinical Psychology in Medical Settings
|
June 6, 2022
Pediatric Consultation-Liaison Psychology: Insights and Lessons Learned During the COVID-19 Pandemic
Nicole M Schneider, Dara M Steinberg, Andrea M Garcia, et al.
The New England Journal of Medicine
|
August 2, 2003
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
James C Yang, Leah Haworth, Richard M Sherry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1995
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy
W H Wilson, S E Bates, A Fojo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1994
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion
W H Wilson, S L Berg, G Bryant, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 26, 2005
Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma
Robert M Dean, Daniel H Fowler, Wyndham H Wilson, et al.
Page
of 152
Search research articles
Search
Showing results (951-960 of 1,520) with videos related to
Sort By:
Page
of 152
Biochemical and Biophysical Research Communications
|
October 12, 2000
Influence of oligomer chain length on the antioxidant activity of procyanidins
S B Lotito, L Actis-Goretta, M L Renart, et al.
Lancet (London, England)
|
July 1, 1995
Treatment of HIV-associated Kaposi's sarcoma with paclitaxel
M W Saville, J Lietzau, J M Pluda, et al.
Blood
|
January 1, 1995
Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies
J Whang-Peng, T Knutsen, E S Jaffe, et al.
Thrombosis Research
|
December 15, 2015
Head trauma is the major risk factor for cerebral sinus-vein thrombosis
Ornit Giladi, David M Steinberg, Kobi Peleg, et al.
Annals of Internal Medicine
|
August 15, 1990
Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy
J M Pluda, R Yarchoan, E S Jaffe, et al.
Journal of Clinical Psychology in Medical Settings
|
June 6, 2022
Pediatric Consultation-Liaison Psychology: Insights and Lessons Learned During the COVID-19 Pandemic
Nicole M Schneider, Dara M Steinberg, Andrea M Garcia, et al.
The New England Journal of Medicine
|
August 2, 2003
A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer
James C Yang, Leah Haworth, Richard M Sherry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1995
Controlled trial of dexverapamil, a modulator of multidrug resistance, in lymphomas refractory to EPOCH chemotherapy
W H Wilson, S E Bates, A Fojo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 1, 1994
Paclitaxel in doxorubicin-refractory or mitoxantrone-refractory breast cancer: a phase I/II trial of 96-hour infusion
W H Wilson, S L Berg, G Bryant, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 26, 2005
Efficacy of reduced-intensity allogeneic stem cell transplantation in chemotherapy-refractory non-hodgkin lymphoma
Robert M Dean, Daniel H Fowler, Wyndham H Wilson, et al.
Page
of 152